BioCentury
ARTICLE | Finance

Quick payday on single cell sale

VC investors get quick double-digit return with DVS-Fluidigm deal

February 3, 2014 8:00 AM UTC

A quick turnaround from first financing to takeout netted investors in DVS Sciences Inc. an impressive return in a short time.

On Jan. 29, Fluidigm Corp. (NASDAQ:FLDM) announced plans to acquire fellow microfluidics company DVS for about $207.5 million. DVS investors will receive about $125 million in cash and $82.5 million in Fluidigm stock...